Amanote Research
Register
Sign In
Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-B-D-Arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma
doi 10.1021/jm0607449.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-Kinase Inhibitor Prodrug
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Novel Point and Combo-Mutations in the Genome of Hepatitis B Virus-Genotype D: Characterization and Impact on Liver Disease Progression to Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma
Place of Liver Transplantation in the Treatment of Hepatocellular Carcinoma in the Normal Liver
Liver Transplantation
Hepatology
Transplantation
Surgery
Characterization of Hepatocellular Adenoma and Carcinoma Using microRNA Profiling and Targeted Gene Sequencing
PLoS ONE
Multidisciplinary
S-1 for Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of the Literature
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Liver Targeted Therapies for Hepatocellular Carcinoma Prior to Transplant: Contemporary Management Strategies
Global Surgery
Molecular Targeted Therapy of Hepatocellular Carcinoma
Journal of Cancer Therapy
The Evaluation of Liver Biopsy Specimens of Chronic Hepatitis B Patients Using Early Tissue Markers for Hepatocellular Carcinoma: Before and After the Development of Hepatocellular Carcinoma
Turkish Journal of Gastroenterology
Gastroenterology
